Ivermectin for COVID-19
4th treatment shown to reduce risk in
August 2020
Lower risk for mortality, ventilation, ICU admission, hospitalization, recovery, cases, and viral clearance.
No treatment is 100% effective. Protocols
combine complementary and synergistic treatments. * >10%
efficacy in meta analysis with ≥3 clinical studies.
4,000+ studies for
60+ treatments. c19ivm.org
|
|
risk of death, 99.8% lower, RR 0.002, p < 0.001, treatment 0 of 3,962 (0.0%), control 471 of 20,921 (2.3%), NNT 44, relative risk is not 0 because of continuity correction due to zero events (with reciprocal of the contrasting arm), All AVUC mild patients vs. Imperial County (corrected).
|
|
risk of hospitalization, 99.8% lower, RR 0.002, p < 0.001, treatment 2 of 3,962 (0.1%), control 4,343 of 20,921 (20.8%), NNT 4.8, All AVUC mild patients vs. Imperial County (corrected).
|
|
risk of death, 97.0% lower, RR 0.03, p < 0.001, treatment 3 of 4,375 (0.1%), control 471 of 20,921 (2.3%), NNT 46, All AVUC patients vs. Imperial County (corrected).
|
|
risk of hospitalization, 99.0% lower, RR 0.010, p < 0.001, treatment 9 of 4,375 (0.2%), control 4,343 of 20,921 (20.8%), NNT 4.9, All AVUC patients vs. Imperial County (corrected).
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
